Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Dew, when you have a moment, can you weigh in as thought leader for this board regarding current status of the situation. It would seem that things are oversold and with the eventual and probable short term approval of MNTA copax 40 that it would be reasonable to expect some modest recovery. My question is whether one should reevaluate the idea that MNTA remains preeminent in making exact copies of biologics or has the basic premise for owning this company changed materially at least until we get to IVIG program. Thanks, bp